Home Applications 209450 Application 209450
Type ANDA
Sponsor AMNEAL PHARMS NY Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 LUBIPROSTONE LUBIPROSTONE CAPSULE;ORAL 8MCG No No 002 LUBIPROSTONE LUBIPROSTONE CAPSULE;ORAL 24MCG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A209450-001 LUBIPROSTONE LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 A209450-002 LUBIPROSTONE LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 74 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-04-04 05:41 UTC 2022-04 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 782e0a99824c…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 053a50430f4f…2023-05-13 08:27 UTC 2023-05 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 e64feba35796…2022-09-29 23:25 UTC 2022-09 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL 2021-11-30 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL 2021-11-30 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A209450-001 LUBIPROSTONE 8MCG CAPSULE / ORAL AB 2021-11-30 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A209450-002 LUBIPROSTONE 24MCG CAPSULE / ORAL AB 2021-11-30 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 60 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 6 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 42291-475 Lubiprostone Lubiprostone AvKARE ANDA Current 42291-476 Lubiprostone Lubiprostone AvKARE ANDA Current 65162-841 Lubiprostone Lubiprostone Amneal Pharmaceuticals LLC ANDA Current 65162-841 Lubiprostone Lubiprostone Amneal Pharmaceuticals LLC ANDA Current 65162-842 Lubiprostone Lubiprostone Amneal Pharmaceuticals LLC ANDA Current 65162-842 Lubiprostone Lubiprostone Amneal Pharmaceuticals LLC ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 67809 ORIG 2021-06-15